COMMUNIQUÉS West-GlobeNewswire

Maple Leaf to Apply for a Dealer’s Licence with the Office of Controlled Substances within Health Canada
15/03/2018
CALGARY, Alberta, March 15, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSXV:MGW) (OTCQB:MGWFF) is pleased to announce that it has engaged Cannabis Compliance Inc. (“ CCI [...]
Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update
15/03/2018
SAN DIEGO, March 15, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) today provided investors with an update concerning certain accomplishments for 2017 and accomplishments and goals for 2018 [...]
Novelion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
15/03/2018
Novelion reports 2017 total net revenues of $138.4 million, in line with previously stated guidance Plans underway to address capital structure and advance metreleptin development program VANCOUVER, British Columbia, [...]
Novelion Therapeutics Subsidiary Enters into $20 Million Term Loan Agreement with Sarissa Capital and Broadfin Capital
15/03/2018
VANCOUVER, British Columbia, March 15, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals for Infringement of Korlym Patents
15/03/2018
MENLO PARK, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT ), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, [...]
Bellerophon Provides Business Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
15/03/2018
WARREN, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and reported [...]
CORRECTING and REPLACING -- BioDelivery Sciences Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
15/03/2018
In a release issued under the same headline earlier today by BioDelivery Sciences International, Inc. (NASDAQ: BDSI ), please note that in the second bullet of the Corporate section, the end date of the non-exclusive [...]
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery
15/03/2018
MINNEAPOLIS, March 15, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., [...]
Dyadic International Appoints Chief Accounting Officer
15/03/2018
JUPITER, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), today announced that Chief Financial Officer Thomas L. Dubinski  will be on a medical leave of absence, effectively [...]
PLx Pharma Inc. to Discuss 2017 Fourth Quarter and Full Year Financial Results on March 23, 2018 Conference Call
15/03/2018
HOUSTON, March 15, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP ) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 [...]
Asterias Biotherapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Developments
15/03/2018
- Achieved Meaningful Progress with Key Clinical Programs - - Anticipate Multiple Data Readouts from SCiStar Study in 2018 into First Quarter of 2019 - - Expect to Enroll First Subject in AST-VAC2 Randomized Clinical [...]
Teligent, Inc. Announces Fourth Quarter and Year End 2017 Results
15/03/2018
BUENA, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth quarter and year ended [...]
OpGen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides a Business Update
15/03/2018
Acuitas® AMR Gene Panel u5.47 introduced for Research Use Only Fourth quarter revenue consistent with previous year; net loss decreases 38% year over year Conference call begins at 4:30 p.m. Eastern time today [...]
Ovid Therapeutics to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call on Thursday, March 29, 2018
15/03/2018
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines for patients with rare neurological disorders, today announced that its [...]
GBT Announces New Employment Inducement Grants
15/03/2018
SOUTH SAN FRANCISCO, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that on March 12, 2018, the compensation committee of the Company’s board of directors [...]
Checkpoint Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights
15/03/2018
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Cara Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
15/03/2018
STAMFORD, Conn., March 15, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]
CymaBay Reports Fourth Quarter and Fiscal 2017 Financial Results and Provides Corporate Update
15/03/2018
Conference call and webcast today at 4:30p.m. ET NEWARK, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies [...]
Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results
15/03/2018
Conference Call & Live Webcast Today at 4:30pm Eastern Time LIVONIA, Mich., March 15, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on [...]

Pages